We compared the pregnancy outcomes between patients with normal or abnormal vaginal microecology (Table 1). Compared with the patients with normal flora, this showed that abnormal vaginal microecology after GDM could significantly increase the frequencies of adverse pregnancy outcomes, including prematurity, premature rupture of membranes, postpartum hemorrhage, fetal distress, low birth weight, and neonatal infection. Moreover, significantly more patients with abnormal flora were delivered by cesarean section than patients with normal flora.However, there were no significant differences in puerperal infection and neonatal asphyxia between the two groups.We compared pregnancy outcomes between the GDM and normal groups (Table S2). In the healthy control group, the proportion of cesarean section was significantly lower than in the GDM group. Moreover, the frequencies of prematurity, puerperal infection, postpartum hemorrhage, fetal distress, neonatal infection, and neonatal asphyxia were significantly higher in the GDM group than the healthy controls. There was no significant difference in low birthweight between the two groups.Our results demonstrate that abnormal vaginal microecology was closely related to adverse pregnancy and neonatal outcomes in women with GDM. Our findings provide evidence for the diagnosis and treatment of vaginal microecological imbalance.
Oral communication abstracts Conclusions: Findings from this study suggest that a discrepancy between the width of the OSA and the expected AoP and HPD represent sonographic indicators of CPD in OA fetuses diagnosed with prolonged first stage of labour.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.